FDA
approval
· 2012-09-20
FDA Approved: MICARDIS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for Micardis (telmisartan) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MICARDIS (TELMISARTAN)